Jeff Patrick, Pharm.D.

Jeff Patrick, Pharm.D. has extensive experience in the pharmaceutical industry. Starting in 2004 as a Medical Science Liaison for Actelion, they have held a variety of roles in the industry, such as Associate Director of Medical Sciences at Myogen, Director of Medical Sciences at Gilead Sciences, Director of Medical Science Liaisons at Covidien, Director of Medical Scientists at Dyax, Vice President of Global Professional Affairs and Vice President of Medical Affairs at Mallinckrodt, Chief Scientific Officer at New Haven Pharmaceuticals, and Institute Director and Director of Drug Development Institute at Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute. In 2019, they joined Nutriband Inc. as Chief Scientific Officer, where they are helping to develop novel technology in transdermal drug delivery.

Jeff Patrick, Pharm.D. earned their Doctorate in Pharmacy from The University of Tennessee Health Science Center in 1997. Prior to this, they pursued Pre-Pharmacy Studies at the University of Tennessee, Knoxville.